Skip to main content
Keyan Salari, MD, Urology, Boston, MA, Massachusetts General Hospital

KeyanSalariMDPhD

Urology Boston, MA

Surgical Oncology

Urologic Oncologist, Massachusetts General Hospital

Dr. Salari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Salari's full profile

Already have an account?

Summary

  • Dr. Keyan Salari is a urologic oncologist in Boston, MA and is affiliated with Massachusetts General Hospital and Harvard Medical School. He received his medical degree from Stanford University School of Medicine and trained at Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. He has been in practice 7 years. He is experienced in urology, oncology, and cancer genomics.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2018 - 2019
  • Massachusetts General Hospital/Harvard Medical School
    Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2014 - 2018
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Surgery, 2012 - 2013
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2012, M.D.
  • Stanford University
    Stanford UniversityPh.D., Genetics, 2010
  • University of California, Berkeley
    University of California, BerkeleyB.A., Molecular and Cell Biology, 2004

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 2012 - 2024
  • RI State Medical License
    RI State Medical License 2021 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2024
  • NY State Medical License
    NY State Medical License 2017 - 2019
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • Detection of Pathogenic Variants with Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients with Prostate Cancer and Melanoma  
    Keyan Salari, MD, JAMA

Press Mentions

  • Genomic Urine Test Detects Bladder Cancer from DNA up to 12 Years Before Clinical Signs and Symptoms Appear
    Genomic Urine Test Detects Bladder Cancer from DNA up to 12 Years Before Clinical Signs and Symptoms AppearMay 1st, 2023
  • Role of HRD in Early-Stage Prostate Cancer
    Role of HRD in Early-Stage Prostate CancerMay 31st, 2022
  • Metabolic Syndrome Post-Prostatectomy Ups Prostate Cancer Death Risk
    Metabolic Syndrome Post-Prostatectomy Ups Prostate Cancer Death RiskSeptember 12th, 2021
  • Join now to see all

Professional Memberships

  • American Urological Association
    Member

Other Languages

  • Spanish, Farsi

Hospital Affiliations